Vertex Pharmaceuticals (VRTX)

Other Income/Expenses (Net)

$144.90M

Quarterly · Period ending: · USD

VRTX logo

VRTX Other Income/Expenses (Net)

Latest reported$144.90M
VRTX Quarterly Other Income/Expenses (Net) (-$500.00K → $144.90M)
High-resolution chart · PNG

VRTX other income/expenses (net) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Other Income/Expenses (Net) — Quarterly (USD)
Period endingOther Income/Expenses (Net) (USD)
144,900,000
114,800,000
30,600,000
112,600,000
131,900,000
100,300,000
110,500,000
107,800,000
123,500,000
139,600,000
159,100,000
141,100,000
135,100,000
112,500,000
43,300,000
49,700,000
-81,900,000
-86,100,000
-6,823,000
28,300,000
-6,300,000
-66,840,000
142,831,000
73,630,000
106,737,000
-62,690,000
125,485,000
-28,667,000
57,178,000
43,357,000
-95,225,000
-69,138,000
43,713,000
85,741,000
-13,295,000
-91,127,000
-17,201,000
-17,309,000
-19,334,000
-20,307,000
-21,374,000
-16,287,000
-22,344,000
-22,460,000
-19,697,000
-26,420,000
-29,133,000
-24,374,000
22,146,000
-14,920,000
-66,091,000
4,656,000
-6,578,000
-4,652,000
-3,296,000
-4,041,000
-3,635,000
-3,741,000
-13,101,000
-15,097,000
-8,980,000
-16,197,000
-13,758,000
-9,369,000
-30,433,000
-4,989,000
-495,459,000
-1,332,000
-14,130,000
-779,000
-469,000
584,000
160,000
2,582,000
5,997,000
6,762,000
7,853,000
7,901,000
-171,958,000
10,325,000
1,564,000
2,669,000
26,394,000
-37,096,000
-2,392,000
-2,320,000
4,964,000
-3,182,000
-2,035,000
-3,890,000
-62,081,000
-1,170,000
-921,000
1,405,000
-52,488,000
2,399,000
0
0
-4,000,000
6,924,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.